Is aggressive surgery necessary for acute postoperative deep spinal wound infection?

Spine

Volumn 33, Issue 22, 2008, Pages 2473-2478

  Hong, Hsu Shan ^a   Chang, Ming Chau ^a,b   Liu, Chien Lin ^c   Chen, Tain Hsiung ^c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c National Yang Ming University School of Medicine ^*

Author keywords

C reactive protein; Conservative treatment; Postoperative spinal infection

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CIPROFLOXACIN; COAGULASE; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADD ON THERAPY; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACKACHE; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONSERVATIVE TREATMENT; DISEASE DURATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEMALE; HUMAN; INFECTION CONTROL; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPINE; SPINE FUSION; SPINE RADIOGRAPHY; STAPHYLOCOCCUS AUREUS; STEVENS JOHNSON SYNDROME; SURGICAL INFECTION; TREATMENT DURATION; TREATMENT OUTCOME; WOUND DRAINAGE; WOUND DRESSING; WOUND HEALING; ACUTE DISEASE; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; ORTHOPEDIC SURGERY; REOPERATION;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; C-REACTIVE PROTEIN; DRAINAGE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; ORTHOPEDIC PROCEDURES; REOPERATION; RETROSPECTIVE STUDIES; SPINE; SURGICAL WOUND INFECTION;

EID: 58149184325     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181894ff0     Document Type: Article

References (40)

1. El-Gindi S, Aref S, Salama M, et al. Infection of intervertebral discs after operation. J Bone Joint Surg Br 1976;58:114-6.
2. Ford LT, Key JA. Postoperative infection of intervertebral disc space. South Med J 1955;48:1295-303.
3. Lindholm TS, Pylkkanen P. Discitis following removal of intervertebral disc. Spine 1982;7:618-22.
4. Stolke D, Sollmann WP, Seifert V. Intra-and postoperative complications in lumbar disc surgery. Spine 1989;14:56-9.
5. Pilgaard S. Discitis (closed space infection) following removal of lumbar intervertebral disc. J Bone Joint Surg Am 1969;51:713-6.
6. Wright RL. Septic Complications of Neurosurgical Spinal Procedures. Springfield, IL: Charles C Thomas; 1970.
7. Gepstein R, Eismont FJ. Postoperative spine infections. In: Garfin SR, ed. Complications of Spine Surgery. Baltimore: Williams & Silkins; 1989:302.
8. Esses SI. The AO spinal internal fixator. Spine 1989;14:373-8.
9. Gurr KR, McAfee PC. Cotrell-Duboussett instrumentation in adults. A preliminary report. Spine 1988;13:510-20.
10. Swank SM, Cohen DS, Brown JC. Spine fusion in cerebral palsy with L-rod segmental spinal instrumentation. A comparison of single and two-stage combined approach with Zielke instrumentation. Spine 1989;14:750-9.
11. Thalgott JS, LaRocca H, Aebi M, et al. Reconstruction of the lumbar spine using AO DCP plate internal fixation. Spine 1989;14:91-5.
12. Whitecloud TS HI, Butler JC, Cohen JL, et al. Complications with the variable spinal plating system. Spine 1989;14:472-6.
13. Heller JG. Postoperative infections of the spine. In: Rothman RH, Simeone FA, eds. The Spine Philadelphia: WB Saunders; 1992:1817.
14. Massie JB, Heller JG, Abitbol JJ, et al. Postoperative posterior spinal wound infections, Clin Orthop Relat Res 1992;284:99-108.
15. Lonstein J, Winter R, Moe J, et al. Wound infection with Harrington instrumentation and spine fusion for scoliosis. Clin Orthop Relat Res 1973;96: 222-33.
16. Levi AD, Dickman CA, Sonntag VK. Management of postoperative infections after spinal instrumentation. J Neurosurg 1997;86:975-80.
17. Theiss SM, Lonstein JE, Winter RB. Wound infections in reconstructive spine surgery. Orthop din North Am 1996;27:105-10.
18. Thalgott JS, Cotler HB, Sasso RC, et al. Postoperative infections in spinal implants: classification and analysis - a multicenter study. Spine 1991;16:981-4.
19. Benzel EC. Medical complications. In: Benzel EC, ed. The Textbook of Spinal Surgery. Philadelphia: Elsevier/Churchhill Livingstone; 2005:2175-6.
20. Wendt JR, Gardner VO, White JI. Treatment of complex postoperative lum-bosacral wounds in nonparalyzed patients. Plast Reconstr Surg 1998;101: 1248-53.
21. Rubayi S. Wound management in spinal infection. Orthop din North Am 1996;27:137-53.
22. Benzel EC. Medical complications. In: Benzel EC, ed. Spine Surgery Techniques, Complication, Avoidance, and Management. Philadelphia: Elsevier/ Churchhill Livingstone; 2005:2014-5.
23. Kink BK, Thurman RT, Wittpenn GP, et al. Muscle flap closure for salvage of complex back wounds. Spine 1994;19:1467-70.
24. Dernbach PD, Gomez H, Hahn J. Primary closure of infected spinal wounds. Neurosurgery 1990;26:707-9.
25. Transfeldt EE, Lonstein JE, Winter RB, et al. Wound infections in reconstructive spinal surgery. Orthop Trans 1985;9:128.
26. Rubinstein E, Findler G, Amit P, et al. Perioperative prophylactic cephazolin in spine surgery. A double-blind placebo-controlled trial. J Bone Joint Surg Br 1994;76:99-102.
27. Hooper DC, Wolfson JS. Fluoroquinolone antimicrobial agents. N Engl J Med 1991;324:384-94.
28. Wolfson JS, Hooper DC. Fluoroquinolone antimicrobial agents, Clin Microbiol Rev 1989;4:378-424.
29. Zimmerli W, Widmer AF, Blatter M, et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections. A randomized controlled trail. JAMA 1998;279:1537-41.
30. Sensi P, Maggi N, Fiiresz S, et al. Chemical modifications and biological properties of rifamycins. Antimicrob Agents Chemother (Bethesda) 1966;6: 699-714.
31. Jensen K. Methicillin-resistant staphylococci [letter]. Lancet 1968;2:1078.
32. Peard MC, Fleck DG, Garrod LP, et al. Combined rifampicin and erythro-mycin for bacterial endocarditis. BMJ 1970;4:410-l.
33. Sande MA, Mandell GA. Effect of rifampin on nasal carriage of Staphylo-coccus aureus. Antimicrob Agents Chemother 1975;7:294-7.
34. Drancourt M, Stein A, Argenson JN, et al. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 1993;37:1214-18.
35. Widmer AF, Gachter A, Ochsner PE, et al. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis 1992;14:1251-3.
36. Widmer AF, Frei R, Rajacic A, et al. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign-body infections. J Infect Dis 1990;162:96-102.
37. Zimmerli W, Frei R, Widmer AF, et al. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 1994;33:959-67.
38. Blaser J, Vergères P, Widmer AF, et al. In vivo verification of an in vitro model of antibiotic treatment of device-related infection. Antimicrob Agents Chemother 1995;39:1134-9.
39. American Academy of Orthopaedic Surgeons Orthopaedic Knowledge Update 8. Illinois: American Academy of Orthopaedic Surgeons; 2005:585.
40. Abbey DM, Turner DM, Warson JS, et al. Treatment of postoperative wound infections following spinal fusion with instrumentation. J Spinal Disord 1995;8:278-83.